BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37074759)

  • 1. Cost-effectiveness of different exercise intensities during oncological treatment in the Phys-Can RCT.
    Ax AK; Husberg M; Johansson B; Demmelmaier I; Berntsen S; Sjövall K; Börjeson S; Nordin K; Davidson T
    Acta Oncol; 2023 Apr; 62(4):414-421. PubMed ID: 37074759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project.
    Ax AK; Husberg M; Johansson B; Demmelmaier I; Berntsen S; Sjövall K; Börjeson S; Nordin K; Davidson T
    Acta Oncol; 2022 Jul; 61(7):888-896. PubMed ID: 35607981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors.
    Kampshoff CS; van Dongen JM; van Mechelen W; Schep G; Vreugdenhil A; Twisk JWR; Bosmans JE; Brug J; Chinapaw MJM; Buffart LM
    J Cancer Surviv; 2018 Jun; 12(3):417-429. PubMed ID: 29497963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term effect of high versus low-to-moderate intensity exercise to optimise health-related quality of life after oncological treatment-results from the Phys-Can project.
    Ax AK; Johansson B; Lyth J; Nordin K; Börjeson S
    Support Care Cancer; 2022 Jul; 30(7):5949-5963. PubMed ID: 35391574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the Resistance and Endurance exercise After ChemoTherapy (REACT) study.
    Kampshoff CS; Chinapaw MJ; Brug J; Twisk JW; Schep G; Nijziel MR; van Mechelen W; Buffart LM
    BMC Med; 2015 Oct; 13():275. PubMed ID: 26515383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and determinants of adherence to resistance and endurance training during cancer treatment in the Phys-Can RCT.
    Brooke HL; Mazzoni AS; Buffart LM; Berntsen S; Nordin K; Demmelmaier I
    BMC Sports Sci Med Rehabil; 2022 Aug; 14(1):155. PubMed ID: 35964124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Moderators of the Effect of High vs. Low-to-Moderate Intensity Exercise on Cardiorespiratory Fitness During Breast Cancer Treatment - Analyses of a Subsample From the Phys-Can RCT.
    Bjørke ACH; Buffart LM; Raastad T; Demmelmaier I; Stenling A; Nordin K; Berntsen S
    Front Sports Act Living; 2022; 4():902124. PubMed ID: 35903402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it safe to exercise during oncological treatment? A study of adverse events during endurance and resistance training - data from the Phys-Can study.
    Henriksson A; Johansson B; Radu C; Berntsen S; Igelström H; Nordin K
    Acta Oncol; 2021 Jan; 60(1):96-105. PubMed ID: 33339484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years.
    Robertson W; Fleming J; Kamal A; Hamborg T; Khan KA; Griffiths F; Stewart-Brown S; Stallard N; Petrou S; Simkiss D; Harrison E; Kim SW; Thorogood M
    Health Technol Assess; 2017 Jan; 21(1):1-180. PubMed ID: 28059054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.
    Palmer R; Dimairo M; Latimer N; Cross E; Brady M; Enderby P; Bowen A; Julious S; Harrison M; Alshreef A; Bradley E; Bhadhuri A; Chater T; Hughes H; Witts H; Herbert E; Cooper C
    Health Technol Assess; 2020 Apr; 24(19):1-176. PubMed ID: 32369007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding web-based behavioural support to exercise referral schemes for inactive adults with chronic health conditions: the e-coachER RCT.
    Taylor AH; Taylor RS; Ingram WM; Anokye N; Dean S; Jolly K; Mutrie N; Lambert J; Yardley L; Greaves C; King J; McAdam C; Steele M; Price L; Streeter A; Charles N; Terry R; Webb D; Campbell J; Hughes L; Ainsworth B; Jones B; Jane B; Erwin J; Little P; Woolf A; Cavanagh C
    Health Technol Assess; 2020 Nov; 24(63):1-106. PubMed ID: 33243368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a physical activity and behaviour maintenance programme on functional mobility decline in older adults: an economic evaluation of the REACT (Retirement in Action) trial.
    Snowsill TM; Stathi A; Green C; Withall J; Greaves CJ; Thompson JL; Taylor G; Gray S; Johansen-Berg H; Bilzon JLJ; de Koning JL; Bollen JC; Moorlock SJ; Western MJ; Guralnik JM; Rejeski WJ; Fox KR; Medina-Lara A
    Lancet Public Health; 2022 Apr; 7(4):e327-e334. PubMed ID: 35325628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term and long-term cost-effectiveness of a pedometer-based exercise intervention in primary care: a within-trial analysis and beyond-trial modelling.
    Anokye N; Fox-Rushby J; Sanghera S; Cook DG; Limb E; Furness C; Kerry SM; Victor CR; Iliffe S; Ussher M; Whincup PH; Ekelund U; deWilde S; Harris T
    BMJ Open; 2018 Oct; 8(10):e021978. PubMed ID: 30337309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
    Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
    Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.